Delivery characteristics of a combined nitric oxide nasal continuous positive airway pressure system

被引:11
作者
Lindwall, R [1 ]
Frostell, CG
Lönnqvist, PA
机构
[1] Danderyd Hosp, Karolinska Inst, Dept Anaesthesia & Intens Care, SE-18288 Stockholm, Sweden
[2] KS Astrid Lindgren Childrens Hosp, Dept Paediat Anaesthesia & Intens Care, Stockholm, Sweden
来源
PAEDIATRIC ANAESTHESIA | 2002年 / 12卷 / 06期
关键词
nitric oxide : administration; dosage; NO2; monitoring; positive-pressure respiration; infant; newborn : lung diseases; therapy;
D O I
10.1046/j.1460-9592.2002.00898.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background : Nitric oxide (NO), when inhaled, has a synergistic effect with airway recruitment strategies such as positive endexpiratory pressure (PEEP) or continuous positive airway pressure (CPAP) in improving oxygenation in lung injury. Methods : We modified a commercially available nasal CPAP (nCPAP) system to enable the concomitant delivery of inhaled NO (iNO) and nCPAP to neonates and term babies. Oxygen, NO and nitrogen dioxide (NO2 ) concentrations were measured, comparing the effects of using 50 or 1000 parts per million (p.p.m.) NO stock gas cylinders. Results : Stable and accurate delivery of iNO was found for both stock gas concentrations. Using a 50 p.p.m. NO stock gas resulted in limited NO2 formation, with a maximum inspired NO2 concentration of less than or equal to 0.3 p.p.m. (dose range up to 37 p.p.m. iNO), which was interpreted as the result of progressive dilution with nitrogen. In contrast, using a 1000 p.p.m. NO stock gas cylinder, inspired NO2 levels increased nonlinearly as expected with an increasing inspired concentration of NO. Conclusions : Inhaled NO can be safely and reliably delivered by the system we describe. The NO2 levels generated by the system are low, at least up to a dose of 37 p.p.m. NO, regardless of a stock gas concentration of 50 or 1000 p.p.m. NO. Using a 50 p.p.m. NO stock gas concentration, up to 80% oxygen can be given at 10 p.p.m. iNO.
引用
收藏
页码:530 / 536
页数:7
相关论文
共 33 条
[1]   Successful weaning from cardiopulmonary bypass after cardiac surgery using inhaled nitric oxide [J].
Bichel, T ;
SpahrSchopfer, I ;
Berner, M ;
Jaeggi, E ;
Velkovski, Y ;
Friedli, B ;
Kalangos, A ;
Faidutti, B ;
Rouge, JC .
PAEDIATRIC ANAESTHESIA, 1997, 7 (04) :335-339
[2]  
Blennow M, 1999, Lakartidningen, V96, P1571
[3]   IMPROVEMENT IN PULMONARY-HYPERTENSION AND HYPOXEMIA DURING NITRIC-OXIDE INHALATION IN A PATIENT WITH END-STAGE PULMONARY FIBROSIS [J].
CHANNICK, RN ;
HOCH, RC ;
NEWHART, JW ;
JOHNSON, FW ;
SMITH, CM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :811-814
[4]   Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. [J].
Clark, RH ;
Kueser, TJ ;
Walker, MW ;
Southgate, WM ;
Huckaby, JL ;
Perez, JA ;
Roy, BJ ;
Keszler, M ;
Kinsella, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (07) :469-474
[5]   Repair of ventricular septal defect in a child with severe pulmonary hypertension - Response to inhaled nitric oxide [J].
Cregg, N ;
Casey, W .
PAEDIATRIC ANAESTHESIA, 1997, 7 (03) :255-258
[6]  
FROSTELL C, 1994, PEDIAT ANAESTHESIA, V4, P147
[7]  
HALLIDAY H, 1977, PEDIATRICS, V60, P444
[8]   Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease [J].
Kinsella, JP ;
Parker, TA ;
Galan, H ;
Sheridan, BC ;
Halbower, AC ;
Abman, SH .
PEDIATRIC RESEARCH, 1997, 41 (04) :457-463
[9]   INHALED NITRIC-OXIDE IMPROVES GAS-EXCHANGE AND LOWERS PULMONARY VASCULAR-RESISTANCE IN SEVERE EXPERIMENTAL HYALINE-MEMBRANE DISEASE [J].
KINSELLA, JP ;
IVY, DD ;
ABMAN, SH .
PEDIATRIC RESEARCH, 1994, 36 (03) :402-408
[10]  
Klausner JF, 1996, PEDIATR PULM, V22, P188, DOI 10.1002/(SICI)1099-0496(199609)22:3<188::AID-PPUL8>3.3.CO